ZYMEWORKS INC (US)(ZYME),Stock Price, Discussion, News, Quote & History - To The Moon - Tiger Brokers Online Investing Community

At the request of the exchanges, the U.S./Hong Kong stock quotes are displayed on a 15-minute delay, download the APP to view the real-time quotes for free.

Close

ZYME ZYMEWORKS INC (US)

Post-Mkt 07-28 16:42:19 EDT

22.61

-0.39

-1.70%

盘后22.61

+0.000.00%

16:10 EDT

High23.50	Low22.35	Vol358.04K
Open23.20	D1 Closing23.00	Amplitude5.00%
Mkt Cap1.65B	Tradable Cap1.55B	Total Shares73.02M
T/O8.09M	T/O Rate0.52%	Tradable Shares68.65M
P/B--	ROE--	EPS0.00
52wk High--	52wk Low--	P/E--
Dividend--	Div.Yield--	ROA--

Loading ...

{"stockData":{"symbol":"ZYME","market":"US","secType":"STK","nameCN":"ZYMEWORKS INC (US)","latestPrice":22.61,"timestamp":1785268800000,"preClose":23,"halted":0,"volume":358040,"hourTrading":{"tag":"盘后","latestPrice":22.61,"preClose":22.61,"latestTime":"16:10 EDT","volume":7413,"amount":167607.099744,"timestamp":1785269405090,"change":0,"changeRate":0,"amplitude":0.009288},"delay":0,"changeRate":-0.01695652173913046,"floatShares":68645200,"shares":73023061,"eps":-1.365952,"marketStatus":"Post-Mkt","change":-0.39,"latestTime":"07-28 16:42:19 EDT","open":23.2,"high":23.5,"low":22.35,"amount":8087581,"amplitude":0.05,"askPrice":23.05,"askSize":86,"bidPrice":20.38,"bidSize":100,"shortable":3,"etf":0,"ttmEps":-1.365952,"tradingStatus":3,"nextMarketStatus":{"tag":"Closed","tradingStatus":0,"beginTime":1785283200000},"marketStatusCode":4,"adr":0,"adrRate":0,"listingDate":1493352000000,"exchange":"NASDAQ","adjPreClose":23,"preHourTrading":{"tag":"盘前","latestPrice":23.3,"preClose":23,"latestTime":"09:29 EDT","volume":1767,"amount":40904.19465,"timestamp":1785245385116,"change":0.3,"changeRate":0.013043,"amplitude":0.130435},"postHourTrading":{"tag":"盘后","latestPrice":22.61,"preClose":22.61,"latestTime":"16:10 EDT","volume":7413,"amount":167607.099744,"timestamp":1785269405090,"change":0,"changeRate":0,"amplitude":0.009288},"volumeRatio":0.999801,"impliedVol":0.3778,"impliedVolPercentile":0.2032},"requestUrl":"/m/hq/s/ZYME/tweets","defaultTab":"tweets","newsList":[{"id":"2651144333","title":"Zymeworks to Report Q2 Results After Market Close","url":"https://stock-news.laohu8.com/highlight/detail?id=2651144333","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2651144333?lang=en_us&edition=fundamental","pubTime":"2026-07-16 18:01","pubTimestamp":1784196095,"startTime":"0","endTime":"0","summary":"Zymeworks to report Q2 results after market closeZymeworks schedules Q2 2026 financial results release for Aug. 6, 2026, issued after the market close.No Q2 earnings conference call planned due to the","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260716:nNDL2VDFlp:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BCDF","BK4588","IE00BN0W2W23.USD","LU2210149790.SGD","LU2210150020.SGD","SG9999014013.SGD","NDAQ","IE00BKPKM429.USD","IE00B3QW5Z07.USD","IE00BN0W2V16.EUR","SG9999014039.USD","BK4007","SG9999014021.USD","ZYME","LU2095319765.USD","IE00BN0W2T93.GBP","BK4585","IE00BGHQF748.EUR","LU0314104364.USD","SG9999014005.SGD","BK4112","BK4139","TBPH","IE00B64PRP62.GBP"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2649282938","title":"Zymeworks price target raised to $31 from $28 at Truist","url":"https://stock-news.laohu8.com/highlight/detail?id=2649282938","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2649282938?lang=en_us&edition=fundamental","pubTime":"2026-07-07 21:21","pubTimestamp":1783430496,"startTime":"0","endTime":"0","summary":"Truist raised the firm’s price target on Zymeworks (ZYME) to $31 from $28 and keeps a Buy rating on the shares as part of a broader research note u...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/zymeworks-price-target-raised-to-31-from-28-at-truist-thefly-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/zymeworks-price-target-raised-to-31-from-28-at-truist-thefly-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["ZYME","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2649980361","title":"Zymeworks is Maintained at Buy by Truist Securities","url":"https://stock-news.laohu8.com/highlight/detail?id=2649980361","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2649980361?lang=en_us&edition=fundamental","pubTime":"2026-07-07 20:40","pubTimestamp":1783428000,"startTime":"0","endTime":"0","summary":"Ratings actions from Benzinga: https://www.benzinga.com/quote/ZYME/analyst-ratings(END) Dow Jones NewswiresJuly 07, 2026 08:40 ET","market":"sg","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","ZYME"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2648654869","title":"Zymeworks Said to Near $929 Million Deal for Theravance - Bloomberg News","url":"https://stock-news.laohu8.com/highlight/detail?id=2648654869","media":"Reuters","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2648654869?lang=en_us&edition=fundamental","pubTime":"2026-07-03 16:13","pubTimestamp":1783066390,"startTime":"0","endTime":"0","summary":"June 29 (Reuters) - :*ZYMEWORKS SAID TO NEAR $929 MILLION DEAL FOR THERAVANCE - BLOOMBERG NEWS*ZYMEWORKS IS DISCUSSING PAYING $17 PER SHARE FOR THERAVANCE- BLOOMBERG NEWS((Reuters Investor Briefs; email: reutersinvestor.briefs@thomsonreuters.com))Source Date/Time = 29-JUN-202609:15:16.917 GMT","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260703:nRSD5YdnzD:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4007","BK4139","TBPH","ZYME"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2648151007","title":"Analysts Offer Insights on Healthcare Companies: Nurix Therapeutics (NRIX), Taysha Gene Therapies (TSHA) and Zymeworks (ZYME)","url":"https://stock-news.laohu8.com/highlight/detail?id=2648151007","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2648151007?lang=en_us&edition=fundamental","pubTime":"2026-07-01 19:50","pubTimestamp":1782906610,"startTime":"0","endTime":"0","summary":"There’s a lot to be optimistic about in the Healthcare sector as 3 analysts just weighed in on Nurix Therapeutics (NRIX), Taysha Gene Therapies (TS...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/blurbs/analysts-offer-insights-on-healthcare-companies-nurix-therapeutics-nrix-taysha-gene-therapies-tsha-and-zymeworks-zyme-blurbs-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/blurbs/analysts-offer-insights-on-healthcare-companies-nurix-therapeutics-nrix-taysha-gene-therapies-tsha-and-zymeworks-zyme-blurbs-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["XLV","LU0029874061.USD","BK4139","BK4137","NRIX","XBI","LABU","ZYME","BK4581","LU0128526141.USD","TSHA","BK4588","BK4585","HCSG"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2647559988","title":"PRESS Digest-canada - June 30","url":"https://stock-news.laohu8.com/highlight/detail?id=2647559988","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2647559988?lang=en_us&edition=fundamental","pubTime":"2026-06-30 21:05","pubTimestamp":1782824734,"startTime":"0","endTime":"0","summary":"PRESS DIGEST-Canada - June 30June 30 (Reuters)-The following are the top stories from selected Canadian newspapers. Reuters has not verified these stories and does not vouch for their accuracy.THE GLO","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260630:nL6N4320PG:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","ZYME","TBPH","BK4007"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2647559095","title":"Analysts Are Bullish on Top Healthcare Stocks: BioCryst (BCRX), Zymeworks (ZYME)","url":"https://stock-news.laohu8.com/highlight/detail?id=2647559095","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2647559095?lang=en_us&edition=fundamental","pubTime":"2026-06-30 20:20","pubTimestamp":1782822013,"startTime":"0","endTime":"0","summary":"There’s a lot to be optimistic about in the Healthcare sector as 2 analysts just weighed in on BioCryst (BCRX) and Zymeworks (ZYME) with bullish se...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/blurbs/analysts-are-bullish-on-top-healthcare-stocks-biocryst-bcrx-zymeworks-zyme-blurbs-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/blurbs/analysts-are-bullish-on-top-healthcare-stocks-biocryst-bcrx-zymeworks-zyme-blurbs-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BCRX","BK4139","BK4547","ZYME"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2647532270","title":"Zymeworks, Inc. : Wells Fargo Raises Target Price to $37 from $34","url":"https://stock-news.laohu8.com/highlight/detail?id=2647532270","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2647532270?lang=en_us&edition=fundamental","pubTime":"2026-06-30 18:25","pubTimestamp":1782815158,"startTime":"0","endTime":"0","summary":null,"market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260630:nAZN4T55ZG:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4139","ZYME"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2647534434","title":"Zymeworks price target raised to $37 from $35 at Citi","url":"https://stock-news.laohu8.com/highlight/detail?id=2647534434","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2647534434?lang=en_us&edition=fundamental","pubTime":"2026-06-30 17:45","pubTimestamp":1782812722,"startTime":"0","endTime":"0","summary":"Citi raised the firm’s price target on Zymeworks (ZYME) to $37 from $35 and keeps a Buy rating on the shares. The firm says the Theravance Biopharm...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/zymeworks-price-target-raised-to-37-from-35-at-citi-thefly-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/zymeworks-price-target-raised-to-37-from-35-at-citi-thefly-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4139","ZYME"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2647905372","title":"Zymeworks Down 6.1%","url":"https://stock-news.laohu8.com/highlight/detail?id=2647905372","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2647905372?lang=en_us&edition=fundamental","pubTime":"2026-06-29 21:32","pubTimestamp":1782739923,"startTime":"0","endTime":"0","summary":null,"market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260629:nL4N43113S:2","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["ZYME","BK4007","TBPH","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2647371469","title":"Zymeworks Posts Investor Presentation on Planned Theravance Biopharma Acquisition for Yupelri Cash Flows","url":"https://stock-news.laohu8.com/highlight/detail?id=2647371469","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2647371469?lang=en_us&edition=fundamental","pubTime":"2026-06-29 20:32","pubTimestamp":1782736336,"startTime":"0","endTime":"0","summary":"Zymeworks posts investor presentation on planned Theravance Biopharma acquisition for YUPELRI cash flowsZymeworks agreed to acquire Theravance Biopharma for USD 929 million; expected closing in 2H26.F","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260629:nNDL6jd7q3:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","ZYME","TBPH","BK4007"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2647795103","title":"Deals of the Day-mergers and Acquisitions","url":"https://stock-news.laohu8.com/highlight/detail?id=2647795103","media":"Reuters","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2647795103?lang=en_us&edition=fundamental","pubTime":"2026-06-29 19:57","pubTimestamp":1782734246,"startTime":"0","endTime":"0","summary":"Deals of the day-Mergers and acquisitionsJune 29 (Reuters)-The following bids, mergers, acquisitions and disposals were reported by 1130 GMT on Monday:** Rocket LabRKLB.Osaid it would acquire satellit","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260629:nL6N4310K4:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4089","LU2237443622.USD","LU1621767737.EUR","IE00BMG7P819.SGD","BK4548","LU1621768115.EUR","BK4213","LU1621768206.USD","LU2237443465.HKD","BK4187","LU0122376428.USD","LU0300736492.USD","LU2384288077.EUR","WMB","IE000WXP2NQ0.USD","LU0345780950.USD","LU0788109394.HKD","LU1621767810.EUR","BK4564","LU0320765489.SGD","LU0368265418.SGD","LU2237443549.SGD","LU2463526074.USD","SG9999001077.SGD","ZYME","BK4007","IRDM","SG9999002521.SGD","IE00BMG7P587.USD","IE00BBT3K403.USD","LU0053666078.USD","IE00BLSP4239.USD","LU2237443382.USD","BK4011","TBPH","LU0345781412.USD","LU0070302665.USD","LU2237443895.HKD","IE00BMG7P926.USD","BK4585","BK4139","LU0053671581.USD","LU0456854461.SGD","MLM","IE000HOSIQF4.USD","IE00BN8TJ469.HKD","IE00BLSP4452.SGD","MTDR","LU0266512473.USD","BK4144","BK4588","LU0300736062.USD","IE00BMG7P694.USD","IE00BMG7P702.HKD","LU2237443978.SGD","LU0054578231.USD","LU0266512127.USD","RKLX","RKLB","LU2237438978.USD","LU0208291251.USD","BK4615","RKLZ","LU0630314457.HKD","IE000SL1IH01.SGD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2647376916","title":"Why This Biotech Stock is Falling After a $929 Million Buyout Lifeline","url":"https://stock-news.laohu8.com/highlight/detail?id=2647376916","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2647376916?lang=en_us&edition=fundamental","pubTime":"2026-06-29 19:26","pubTimestamp":1782732360,"startTime":"0","endTime":"0","summary":"Shares of Theravance Biopharma were sliding in premarket trading Monday after larger biotech Zymeworks agreed to acquire the company for roughly $929 million.Under the terms of the deal, Zymeworks wil","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["XBI","BK4588","BK4585","ZYME","BK4581","BK4139","TBPH","BK4007"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2647637317","title":"Theravance Biopharma: Co to Pay $32.5 Mln Termination Fee to Zymeworks, if Deal Terminated Under Certain Circumstances","url":"https://stock-news.laohu8.com/highlight/detail?id=2647637317","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2647637317?lang=en_us&edition=fundamental","pubTime":"2026-06-29 18:35","pubTimestamp":1782729327,"startTime":"0","endTime":"0","summary":null,"market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260629:nFWN43109I:2","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4007","BK4139","TBPH","ZYME"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2647737387","title":"Theravance Biopharma to be acquired by Zymeworks for $17.00 per share in cash","url":"https://stock-news.laohu8.com/highlight/detail?id=2647737387","media":"TIPRANKS","labels":["corporation","merge"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2647737387?lang=en_us&edition=fundamental","pubTime":"2026-06-29 18:15","pubTimestamp":1782728132,"startTime":"0","endTime":"0","summary":"Theravance Biopharma (TBPH) announced that it has entered into a definitive agreement pursuant to which Zymeworks (ZYME) will acquire the company f...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/theravance-biopharma-to-be-acquired-by-zymeworks-for-17-00-per-share-in-cash-thefly-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/theravance-biopharma-to-be-acquired-by-zymeworks-for-17-00-per-share-in-cash-thefly-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"corporation,merge","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4007","BK4139","ZYME","TBPH"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2647378576","title":"Theravance Biopharma Shares Fall 3.3% Premarket; Co to be Acquired by Zymeworks for $17 Per Share in Cash Plus a Contingent Value Right","url":"https://stock-news.laohu8.com/highlight/detail?id=2647378576","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2647378576?lang=en_us&edition=fundamental","pubTime":"2026-06-29 18:03","pubTimestamp":1782727438,"startTime":"0","endTime":"0","summary":null,"market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260629:nL4N4310QW:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4007","TBPH","ZYME","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2647378840","title":"Zymeworks to Acquire Theravance Biopharma for USD 17 Per Share in USD 929 Million Deal","url":"https://stock-news.laohu8.com/highlight/detail?id=2647378840","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2647378840?lang=en_us&edition=fundamental","pubTime":"2026-06-29 18:00","pubTimestamp":1782727229,"startTime":"0","endTime":"0","summary":"Zymeworks to acquire Theravance Biopharma for USD 17 per share in USD 929 million dealZymeworks agreed to buy Theravance Biopharma for USD 17 per share, valuing the deal at about USD 929 million in ca","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260629:nNDL3V7KG9:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4585","IE00BGHQF748.EUR","IE00B64PRP62.GBP","BK4139","SG9999014005.SGD","BK4588","IE00BN0W2V16.EUR","TBPH","NDAQ","LU2210150020.SGD","LU0314104364.USD","IE00BN0W2T93.GBP","SG9999014021.USD","SG9999014039.USD","ZYME","LU2210149790.SGD","IE00B3QW5Z07.USD","SG9999014013.SGD","BK4112","IE00BN0W2W23.USD","LU2095319765.USD","BK4007","IE00BKPKM429.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2647378381","title":"Theravance Biopharma - Strategic Review Committee and Board Unanimously Approve and Recommend Deal","url":"https://stock-news.laohu8.com/highlight/detail?id=2647378381","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2647378381?lang=en_us&edition=fundamental","pubTime":"2026-06-29 18:00","pubTimestamp":1782727202,"startTime":"0","endTime":"0","summary":null,"market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260629:nTUA56BSJH:5","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["ZYME","TBPH","BK4007","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2647378356","title":"Theravance Biopharma - Deal Represents Equity Value of About $929 Mln","url":"https://stock-news.laohu8.com/highlight/detail?id=2647378356","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2647378356?lang=en_us&edition=fundamental","pubTime":"2026-06-29 18:00","pubTimestamp":1782727202,"startTime":"0","endTime":"0","summary":null,"market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260629:nTUA56BSJH:3","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4139","TBPH","BK4007","ZYME"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2647337378","title":"Theravance Biopharma - to be Bought by Zymeworks for $17 Per Share in Cash Plus CVR","url":"https://stock-news.laohu8.com/highlight/detail?id=2647337378","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2647337378?lang=en_us&edition=fundamental","pubTime":"2026-06-29 18:00","pubTimestamp":1782727202,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260629:nTUA56BSJH:2","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4007","BK4139","TBPH","ZYME"],"isVideo":false,"video":null,"gpt_icon":0}],"profile":{"websiteUrl":"http://www.zymeworks.com","stockEarnings":[{"period":"1week","weight":-0.032},{"period":"1month","weight":-0.0476},{"period":"3month","weight":-0.1768},{"period":"6month","weight":0.0309},{"period":"1year","weight":0.7254},{"period":"ytd","weight":-0.1265}],"compareEarnings":[{"period":"1week","weight":-0.004},{"period":"1month","weight":0.0139},{"period":"3month","weight":0.0385},{"period":"6month","weight":0.0628},{"period":"1year","weight":0.1601},{"period":"ytd","weight":0.0838}],"compareStock":{"symbol":"SPY","name":"SPDR S&P 500 ETF Trust"},"description":"","yearOnYearQuotes":[{"month":1,"riseRate":0.444444,"avgChangeRate":0.015488},{"month":2,"riseRate":0.333333,"avgChangeRate":-0.056871},{"month":3,"riseRate":0.444444,"avgChangeRate":-0.020874},{"month":4,"riseRate":0.666667,"avgChangeRate":0.045958},{"month":5,"riseRate":0.3,"avgChangeRate":0.007371},{"month":6,"riseRate":0.6,"avgChangeRate":-0.037508},{"month":7,"riseRate":0.4,"avgChangeRate":-0.039864},{"month":8,"riseRate":0.888889,"avgChangeRate":0.104131},{"month":9,"riseRate":0.444444,"avgChangeRate":0.038592},{"month":10,"riseRate":0.666667,"avgChangeRate":0.043198},{"month":11,"riseRate":0.777778,"avgChangeRate":0.135367},{"month":12,"riseRate":0.555556,"avgChangeRate":0.004939}],"exchange":"NASDAQ","name":"ZYMEWORKS INC (US)","nameEN":"ZYMEWORKS INC (US)"},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":true,"isLaohu8Offline":false,"tenantId":"TBGLOBAL","deviceId":"web-server-community-laohu8-v3","version":"4.46.0","shortVersion":"4.46.0","platform":"web","vendor":"web","appName":"ttm","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"ZYMEWORKS INC (US)(ZYME),Stock Price, Discussion, News, Quote & History - To The Moon - Tiger Brokers Online Investing Community","description":"Find the latest ZYMEWORKS INC (US)(ZYME) stock quote, history, news, and investing ideas from To The Moon - Tiger Brokers Online Investing Community to stay on top of the markets.","keywords":"ZYMEWORKS INC (US),ZYME,ZYMEWORKS INC (US)股票,ZYMEWORKS INC (US)股票老虎,ZYMEWORKS INC (US)股票老虎国际,ZYMEWORKS INC (US)行情,ZYMEWORKS INC (US)股票行情,ZYMEWORKS INC (US)股价,ZYMEWORKS INC (US)股市,ZYMEWORKS INC (US)股票价格,ZYMEWORKS INC (US)股票交易,ZYMEWORKS INC (US)股票购买,ZYMEWORKS INC (US)股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"ZYMEWORKS INC (US)(ZYME),Stock Price, Discussion, News, Quote & History - To The Moon - Tiger Brokers Online Investing Community","og_description":"Find the latest ZYMEWORKS INC (US)(ZYME) stock quote, history, news, and investing ideas from To The Moon - Tiger Brokers Online Investing Community to stay on top of the markets.","og_image":"https://community-static.tradeup.com/news/9b6dafd60190235ae8e2c95f52c583a0"}}}

Introduction